NewMarket Corp (NEU) stock
NEUNYSEIndustrial Organic ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3014% below fair value
$709.19+6.30 (+0.90%)
Close on Nov 13, 2026Market cap $6.52BP/E 14.4Yield 1.59%
NewMarket EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
NewMarket's EPS for the twelve months ending Sep 30, 2026 was $49.31, up 4.2% year over year. For fiscal 2025 it was $44.44, down 7.8% from the year before. Over ten years it grew 8.6% a year on average. The highest annual figure on record is $48.22 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.44 | -7.8% |
| FY2024 | Dec 31, 2024 | $48.22 | +19.2% |
| FY2023 | Dec 31, 2023 | $40.44 | +45.6% |
| FY2022 | Dec 31, 2022 | $27.77 | +56.8% |
| FY2021 | Dec 31, 2021 | $17.71 | -28.1% |
| FY2020 | Dec 31, 2020 | $24.64 | +8.4% |
| FY2019 | Dec 31, 2019 | $22.73 | +11.8% |
| FY2018 | Dec 31, 2018 | $20.34 | +26.5% |
| FY2017 | Dec 31, 2017 | $16.08 | -21.7% |
| FY2016 | Dec 31, 2016 | $20.54 | +5.6% |
| FY2015 | Dec 31, 2015 | $19.45 | +5.8% |
| FY2014 | Dec 31, 2014 | $18.38 | -7.6% |
| FY2013 | Dec 31, 2013 | $19.90 | +11.5% |
| FY2012 | Dec 31, 2012 | $17.85 | +18.3% |
| FY2011 | Dec 31, 2011 | $15.09 | +24.8% |
| FY2010 | Dec 31, 2010 | $12.09 | +13.5% |
| FY2009 | Dec 31, 2009 | $10.65 | +124.2% |
| FY2008 | Dec 31, 2008 | $4.75 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $13.50 | +26.5% |
| Q2 FY2026 | Jun 30, 2026 | $14.54 | +22.8% |
| Q1 FY2026 | Mar 31, 2026 | $12.62 | -4.8% |
| Q4 FY2025 | Dec 31, 2025 | $8.65 | -25.2% |
| Q3 FY2025 | Sep 30, 2025 | $10.67 | -22.6% |
| Q2 FY2025 | Jun 30, 2025 | $11.84 | +1.8% |
| Q1 FY2025 | Mar 31, 2025 | $13.26 | +18.1% |
| Q4 FY2024 | Dec 31, 2024 | $11.56 | +37.9% |
| Q3 FY2024 | Sep 30, 2024 | $13.79 | +18.9% |
| Q2 FY2024 | Jun 30, 2024 | $11.63 | +12.3% |
| Q1 FY2024 | Mar 31, 2024 | $11.23 | +11.3% |
| Q4 FY2023 | Dec 31, 2023 | $8.38 | -9.4% |
| Q3 FY2023 | Sep 30, 2023 | $11.60 | +83.5% |
| Q2 FY2023 | Jun 30, 2023 | $10.36 | +58.4% |
| Q1 FY2023 | Mar 31, 2023 | $10.09 | +75.5% |
| Q4 FY2022 | Dec 31, 2022 | $9.25 | +460.6% |
| Q3 FY2022 | Sep 30, 2022 | $6.32 | +31.7% |
| Q2 FY2022 | Jun 30, 2022 | $6.54 | +37.7% |
| Q1 FY2022 | Mar 31, 2022 | $5.75 | -9.9% |
| Q4 FY2021 | Dec 31, 2021 | $1.65 | -73.0% |
| Q3 FY2021 | Sep 30, 2021 | $4.80 | -45.3% |
| Q2 FY2021 | Jun 30, 2021 | $4.75 | +131.7% |
| Q1 FY2021 | Mar 31, 2021 | $6.38 | -16.8% |
| Q4 FY2020 | Dec 31, 2020 | $6.12 | +36.6% |
| Q3 FY2020 | Sep 30, 2020 | $8.77 | +44.7% |
| Q2 FY2020 | Jun 30, 2020 | $2.05 | -69.1% |
| Q1 FY2020 | Mar 31, 2020 | $7.67 | +37.7% |
| Q4 FY2019 | Dec 31, 2019 | $4.48 | -19.7% |
| Q3 FY2019 | Sep 30, 2019 | $6.06 | +18.4% |
| Q2 FY2019 | Jun 30, 2019 | $6.63 | +46.4% |
| Q1 FY2019 | Mar 31, 2019 | $5.57 | +8.4% |
| Q4 FY2018 | Dec 31, 2018 | $5.58 | +1494.3% |
| Q3 FY2018 | Sep 30, 2018 | $5.12 | +1.6% |
| Q2 FY2018 | Jun 30, 2018 | $4.53 | -14.4% |
| Q1 FY2018 | Mar 31, 2018 | $5.14 | -4.6% |
| Q4 FY2017 | Dec 31, 2017 | $0.35 | -90.9% |
| Q3 FY2017 | Sep 30, 2017 | $5.04 | – |
| Q2 FY2017 | Jun 30, 2017 | $5.29 | – |
| Q1 FY2017 | Mar 31, 2017 | $5.39 | – |
| Q4 FY2016 | Dec 31, 2016 | $3.86 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?